The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123489242 12348924 2 F 20150819 20160728 20160509 20160805 EXP DK-ELI_LILLY_AND_COMPANY-DK201604010660 ELI LILLY AND CO 44.20 YR F Y 54.00000 KG 20160805 MD DK DK

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123489242 12348924 1 PS CYMBALTA DULOXETINE HYDROCHLORIDE 1 Oral 30 MG, QD 21427 30 MG CAPSULE QD
123489242 12348924 2 SS CYMBALTA DULOXETINE HYDROCHLORIDE 1 Unknown UNK, UNKNOWN 21427 30 MG CAPSULE
123489242 12348924 3 SS CYMBALTA DULOXETINE HYDROCHLORIDE 1 Unknown UNK, UNKNOWN 21427 CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123489242 12348924 1 Fibromyalgia
123489242 12348924 2 Depression

Outcome of event

Event ID CASEID OUTC COD
123489242 12348924 OT
123489242 12348924 DS
123489242 12348924 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
123489242 12348924 Activities of daily living impaired
123489242 12348924 Anxiety
123489242 12348924 Blood cholesterol increased
123489242 12348924 Blood prolactin increased
123489242 12348924 Cerebral disorder
123489242 12348924 Decreased appetite
123489242 12348924 Dizziness
123489242 12348924 Drug withdrawal convulsions
123489242 12348924 Drug withdrawal syndrome
123489242 12348924 Fear
123489242 12348924 Headache
123489242 12348924 Heart rate increased
123489242 12348924 Hemiplegia
123489242 12348924 Hypertension
123489242 12348924 Hypohidrosis
123489242 12348924 Insomnia
123489242 12348924 Malaise
123489242 12348924 Micturition urgency
123489242 12348924 Nausea
123489242 12348924 Neoplasm
123489242 12348924 Off label use
123489242 12348924 Palpitations
123489242 12348924 Panic disorder
123489242 12348924 Paraesthesia
123489242 12348924 Postmenopausal haemorrhage
123489242 12348924 Speech disorder
123489242 12348924 Ulcer haemorrhage
123489242 12348924 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123489242 12348924 1 20090401 20150819 0